tilbroquinol has been researched along with oxyquinoline in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (25.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (50.00) | 24.3611 |
2020's | 1 (25.00) | 2.80 |
Authors | Studies |
---|---|
Basdevant, A; Guy-Grand, B; Raison, J; Sarragoussi, JJ; Soffer, M | 1 |
Alison, D; Bailly, E; Bastides, F; Bernard, L; Brunereau, L; Chandenier, J; Chaussade, H; Desoubeaux, G; Lanotte, P; Poussing, S; Thellier, M | 1 |
Abou-Bacar, A; Betz, V; Brunet, J; Candolfi, E; Christmann, D; Filisetti, D; Gagnard, JC; Hannedouche, T; Hansmann, Y; Krummel, Y; Nespola, B; Pesson, B; Pfaff, AW | 1 |
Cooper, C; Ekpenyong, O; Gao, X; Liang, D; Ma, J; Nguyen, L; Olaleye, OA; Xie, H | 1 |
4 other study(ies) available for tilbroquinol and oxyquinoline
Article | Year |
---|---|
Oxyquinoline toxicity.
Topics: Clioquinol; Diverticulum; Drug Combinations; France; Humans; Hydroxyquinolines; Male; Middle Aged; Myelitis; Optic Neuritis; Oxyquinoline; Syndrome | 1983 |
Unusual multiple large abscesses of the liver: interest of the radiological features and the real-time PCR to distinguish between bacterial and amebic etiologies.
Topics: Adult; Antibodies, Protozoan; Antiprotozoal Agents; Asthenia; Diarrhea; Dysentery, Amebic; Entamoeba histolytica; Feeding and Eating Disorders; Fever; Humans; Liver Abscess, Amebic; Male; Metronidazole; Oxyquinoline; Real-Time Polymerase Chain Reaction; Tomography, X-Ray Computed; Travel; Treatment Outcome; Ultrasonography, Interventional | 2014 |
First case of amebic liver abscess 22 years after the first occurrence.
Topics: Acute Kidney Injury; Aged; Antibodies, Protozoan; Antiprotozoal Agents; Bacterial Infections; Diagnostic Errors; Drug Therapy, Combination; Entamoeba histolytica; France; Humans; Liver Abscess, Amebic; Male; Metronidazole; Oxyquinoline; Senegal; Time Factors; Tomography, X-Ray Computed; Travel; Trimethoprim, Sulfamethoxazole Drug Combination; West Indies | 2015 |
Pre-Clinical Pharmacokinetics, Tissue Distribution and Physicochemical Studies of CLBQ14, a Novel Methionine Aminopeptidase Inhibitor for the Treatment of Infectious Diseases.
Topics: Animals; Chemistry, Physical; Communicable Diseases; Enzyme Inhibitors; Heart; Humans; Kidney; Macaca fascicularis; Male; Methionyl Aminopeptidases; Mice; Molecular Structure; Oxyquinoline; Rats; Rats, Sprague-Dawley; Thermodynamics; Tissue Distribution | 2020 |